Omic Technologies to Track Resistance to Palbociclib in Metastatic Breast Cancer

NCT04653740 · clinicaltrials.gov ↗

NA

Phase

ACTIVE_NOT_RECRUITING

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Advanced Breast Cancer

Interventions

PROCEDURE: specimen sample collection

Sponsor

Centre Oscar Lambret

Collaborators

[object Object]